Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study checks if sending new moms home early is safe

NCT ID NCT03114930

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at what happens to mothers and their newborns in the first month after going home from the hospital earlier than usual. It included 177 mothers and babies who were sent home after a short hospital stay. The goal was to see if early discharge leads to any health problems or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

177 people

The number who actually took part.

Started

Mar 2016

Finished

Dec 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be taken care of in the Maternity Department of the Amiens-Picardie University Hospital. * Parents' agreement * Mother and Newborn who meet the eligibility criteria of the HAS for a "standard" exit. Mother : * 1\. Absence of a situation of psychological, social vulnerability, behaviors of addiction and severe dependencies * 2\. Adequate family and / or social support * 3\. Absence of chronic ill-balanced pathology * 4\. Absence of complications or pathologies requiring observation or continuous medical treatment * 5\. Absence of haemorrhage of the delivery, this one was checked and treated (if necessary) * 6\. Absence of active infection or signs of infection * 7\. Absence of thromboembolic signs * 8\. Controlled Pain * 9\. Satisfactory mother-child interactions Child: * 1\. Newborn at term ≥ 37 weeks of amenorrhea, singleton and eutroph * 2\. Normal clinical examination performed imperatively 48 hours after birth and before discharge * 3\. Axillary temperature between 36 and 37 ° C or central between 36.5 and 37.5 ° C * 4\. Established feeding (if breastfeeding: observation of at least 2 feeds ensuring effective transfer of colostrum / milk recognized by the mother), urination and spontaneous stool emissions, established transit * 5\. Weight loss \<8% of birth weight * 6\. Absence of jaundice requiring phototherapy according to the therapeutic indication curve and measurement of transcutaneous and / or blood bilirubin at the output referred to the nomogram (low risk and low intermediate risk only) * 7\. Lack of clinical or paraclinical evidence for infection; If risk factors of infection: recovered and negative biological and bacteriological samples * 8\. Planned neonatal screening and traceability * 9\. Post-partum follow-up after the organized event: an appointment with a referral professional within 48 hours following the exit or even in the week Exclusion Criteria: * Patient not speaking French * Patient who does not meet the HAS criteria: newborn or ineligible mother (minor mother, non-singleton birth) * Assumption in another department than the Maternity department of the CHU Amiens-Picardie.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Maternity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens Picardie

    Amiens, Picardie, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.